The narrow concept of mild cognitive impairment (MCI) as an early form of Alzheimer’s disease has been broadened by research that established the existence of alternative forms of the condition that may presage other forms of dementia. The research presented here was a naturalistic, cross-sectional study of patients in a community referral clinic—patients with MCI and mild dementia—compared to normal controls.
A comprehensive, computerized neurocognitive screening battery developed by one of the authors (CNS Vital Signs) was administered to all of the subjects. Participants consisted of 36 patients with MCI and 53 patients with mild dementia, diagnosed by standard criteria, and 89 matched normal controls. Multivariate analysis indicated significant differences among the three groups for all 15 primary test variables and for all five of the domain scores. Tests of memory, processing speed, and cognitive flexibility were the most cogent discriminators between normal controls and MCI patients, and between MCI patients and patients with mild dementia. The same three tests also had the greatest sensitivity and specificity.
The results of this study indicate that computerized testing can differentiate among normal controls, MCI patients, and patients with mild dementia. Also, in a diverse group of MCI and mild dementia patients, impairments in memory, processing speed, and cognitive flexibility were the most prominent observed deficits.
Grundman M, Petersen RC, Ferris SH, et al.: Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004; 61: 59-66.
2.
Tierney MC, Szalai JP, Dunn E, et al.: Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Value of the Mini-Mental State Examination. Arch Fam Med. 2000; 9: 527-532.
3.
Morris JN, Fries BE, Mehr DR, et al.: MDS Cognitive Performance Scale. J Gerontol. 1994; 49: 174-182.
4.
Petersen RC: Mild Cognitive Impairment: Aging to Alzheimer’s Disease. New York: Oxford University Press, 2003.
5.
Almkvist O, Winblad B: Early diagnosis of Alzheimer dementia based on clinical and biological factors. Eur Arch Psychiatr Clin Neurosci. 1999; 249: 3-9.
6.
Winblad B, Palmer K, Kivipelto M, et al.: Introduction: Mild cognitive impairment: Beyond controversies, towards a consensus. J Int Med. 2004; 256: 181-182.
7.
Chen P, Ratcliff G, Belle SH, et al.: Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented [comment]. Neurology. 2000; 55: 1847-1853.
8.
Bruscoli M, Lovestone S: Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004; 16: 129-140.
9.
Arnaiz E, Almkvist O, Ivnik RJ, et al.: Mild cognitive impairment: A cross-national comparison. J Neurol Neurosurg Psychiatry. 2004; 75: 1275-1280.
10.
Collie A, Maruff P: An analysis of systems of classifying mild cognitive impairment in older people. Aust NZ J Psychiatr. 2002; 36: 133-140.
Lopez OL, Jagust WJ, DeKosky ST, et al.: Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: Part 1. Arch Neurol. 2003; 60: 1385-1389.
15.
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Int Med. 2004; 256: 183-194.
16.
Davis HS, Rockwood K: Conceptualization of mild cognitive impairment: A review. Int J Geriatr Psychiatry. 2004; 19: 313-319.
17.
Kivipelto M, Helkala EL, Hanninen T, et al.: Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology. 2001; 56: 1683-1689.
18.
Busse A, Bischkopf J, Riedel-Heller SG, et al.: Subclassifications for mild cognitive impairment: Prevalence and predictive validity. Psychol Med. 2003; 33: 1029-1038.
19.
Gualtieri CT, Johnson LG, Benedict KB: Reliability and validity of a new computerized test battery. Baltimore. 2004. Presented at the International Neuropsychological Society Annual Meeting, February 4-7, 2004, Baltimore, MD.
20.
Gualtieri CT, Johnson LG, Benedict KB: A computerized cognitive screening battery for psychiatrists. Presented at the American Psychiatric Association Annual Meeting, May 1-6, 2004, New York, NY.
21.
Gualtieri CT, Johnson LG, Benedict KB: Reliability and validity of a brief computerized neurocognitive screening battery. Presented at the International Neuropsychological Society Annual Meeting, February 4-7, 2004, Baltimore, MD.
22.
Benedict KB, Benson J: The Use of CNSVS in college students with primary attention and/or learning disorders. 16th Annual Postsecondary Disability Training Institute (PTI), Mount Snow, VT, June 8-12, 2004.
23.
Binetti G, Magni E, Padovani A, et al.: Neuropsychological heterogeneity in mild Alzheimer’s disease. Dementia. 1993; 4: 321-326.
24.
Kane RL, Kay GG: Computerized assessment in neuropsychology: A review of tests and test batteries. Neuropsychol Rev. 1992; 3: 1-117.
25.
Lawrence AD, Hodges JR, Rosser AE, et al.: Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain. 1998; 121: 1329-1341.
26.
Fowler KS, Saling MM, Conway EL, et al.: Computerized neuropsychological tests in the early detection of dementia: Prospective findings. J Int Neuropsychol Soc. 1997; 3: 139-146.
Krengel M, White RF, Diamond R, et al.: A comparison of NES2 and traditional neuropsychological tests in a neurologic patient sample. Neurotoxicol Teratol. 1996; 18: 435-439.
29.
Baker EL, Letz RE, Fidler AT, et al.: A computer-based neurobehavioral evaluation system for occupational and environmental epidemiology: Methodology and validation studies. Neurobehav Toxicol Teratol. 1985; 7: 369-377.
30.
Baker EL, Letz R, Fidler AT: A computer-administered neurobehavioral evaluation system for occupational and environmental epidemiology. Rationale, methodology, and pilot study results. J Occupat Med. 1985; 27: 206-212.
31.
Arcia E, Gualtieri CT: Neurobehavioural performance of adults with closed-head injury, adults with attention deficit, and controls. Brain Injury. 1994; 8: 395-404.
32.
Anger WK, Otto DA, Letz R: Symposium on computerized behavioral testing of humans in neurotoxicology research: Overview of the proceedings. Neurotoxicol Teratol. 1996; 18: 347-350.
33.
Maruff P, Collie A, Darby D, et al.: Subtle memory decline over 12 months in mild cognitive impairment. Dementia Geriatr Cog Disord. 2004; 18: 342-348.
34.
White L, Petrovitch H, Ross GW, et al.: Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA. 1996; 276: 955-960.
35.
Linn RT, Wolf PA, Bachman DL, et al.: The “preclinical phase” of probable Alzheimer’s disease. A 13-year prospective study of the Framingham cohort. Arch Neurol. 1995; 52: 485-490.
36.
Dubois B, Albert ML: Amnestic MCI or prodromal Alzheimer’s disease?Lancet Neurol. 2004; 3: 246-248.
37.
Petersen RC, Stevens JC, Ganguli M, et al.: Practice parameter: Early detection of dementia: mild cognitive impairment (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56: 1133-1142.
